Olin
- Market cap
- 1.81B
- P/E (TTM)i
- -9.20
- P/Bi
- 1.06
- EPSi
- -0.88
- Div yieldi
- 5.03%
- 52W posi
- 6%
Anonymous reader poll. Unscientific, not investment advice.
Valuation each multiple against its own 5-year range
Vs. peers Chemicals
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Olin (OLN) | 1.81B | -9.20 | 1.06 | 5.03% |
| Dow Inc (DOW) | 20.06B | -15.17 | 1.26 | 5.04% |
| Celanese Corp (CE) | 4.81B | -4.11 | 1.16 | 0.27% |
| Methanex (MEOH) | 4.67B | 63.59 | 1.82 | 1.22% |
| Huntsman (HUN) | 1.51B | -8.22 | 0.56 | 5.94% |
| REX American Resources (REX) | 1.47B | 12.14 | 2.18 | 0.00% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 72.8% below Morningstar's fair value estimate.
Fair value
Olin Corp receives a 5-star quantitative star rating, reflecting our opinion that this share class offers a compelling opportunity for investors. The stock currently trades at a 41% discount to our quantitative fair value estimate of $27.51 per share; however, caution is warranted due to this estimate's high uncertainty rating.
The company's valuation metrics strengthen our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. For example, the firm's enterprise value to EBITDA ratio of 8.9 lies in the bottom 40% compared with global peers. Relative to the company's EBITDA, the enterprise value of the business is low, which contributes to our view that shares are undervalued.
The firm's balance sheet is an additional encouraging factor. Leverage can enable a company to invest in growth, potentially boosting shareholder value more than equity financing alone. The firm's EBITDA/interest coverage ratio of 2.3, for example, sits in the bottom 20% globally. Although the firm's ability to cover interest payments with EBITDA is limited, shares could sharply rebound if economic circumstances change or recent investments reduce fears of default. This characteristic further promotes our favorable price/fair value ratio.
Economic moat
With its quantitative economic moat rating of none, this business is unlikely to consistently outearn its cost of capital without structural protection from competition. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.
By Quantitative Equity Report
Quote time 2026-10-07 21:13:59 · For reference only, not investment advice and not tailored to your situation.